Murine models for mucosal tolerance in allergy
- PMID: 28807539
- PMCID: PMC7100013
- DOI: 10.1016/j.smim.2017.07.007
Murine models for mucosal tolerance in allergy
Abstract
Immunity is established by a fine balance to discriminate between self and non-self. In addition, mucosal surfaces have the unique ability to establish and maintain a state of tolerance also against non-self constituents such as those represented by the large numbers of commensals populating mucosal surfaces and food-derived or air-borne antigens. Recent years have seen a dramatic expansion in our understanding of the basic mechanisms and the involved cellular and molecular players orchestrating mucosal tolerance. As a direct outgrowth, promising prophylactic and therapeutic models for mucosal tolerance induction against usually innocuous antigens (derived from food and aeroallergen sources) have been developed. A major theme in the past years was the introduction of improved formulations and novel adjuvants into such allergy vaccines. This review article describes basic mechanisms of mucosal tolerance induction and contrasts the peculiarities but also the interdependence of the gut and respiratory tract associated lymphoid tissues in that context. Particular emphasis is put on delineating the current prophylactic and therapeutic strategies to study and improve mucosal tolerance induction in allergy.
Keywords: Allergy; Animal models; BALT; Commensals; GALT; Mucosal tolerance; NALT; Regulatory T cells.
Copyright © 2017. Published by Elsevier Ltd.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eaf/7100013/13d185da02ca/EMS86000-f001.gif)
Similar articles
-
Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs.Curr Drug Targets Inflamm Allergy. 2005 Oct;4(5):577-83. doi: 10.2174/156801005774322207. Curr Drug Targets Inflamm Allergy. 2005. PMID: 16248826 Review.
-
Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.Immunol Allergy Clin North Am. 2006 May;26(2):283-306, vii-viii. doi: 10.1016/j.iac.2006.02.009. Immunol Allergy Clin North Am. 2006. PMID: 16701145 Review.
-
Induction of allergen-specific tolerance via mucosal routes.Curr Top Microbiol Immunol. 2011;352:85-105. doi: 10.1007/82_2011_132. Curr Top Microbiol Immunol. 2011. PMID: 21562971 Review.
-
Oral tolerance and allergy.Semin Immunol. 2017 Apr;30:28-35. doi: 10.1016/j.smim.2017.07.001. Epub 2017 Jul 21. Semin Immunol. 2017. PMID: 28739336 Review.
-
[Mucosal immunity and vaccine development].Med Sci (Paris). 2007 Apr;23(4):371-8. doi: 10.1051/medsci/2007234371. Med Sci (Paris). 2007. PMID: 17433226 Review. French.
Cited by
-
Reduction of Allergic Lung Disease by Mucosal Application of Toxoplasma gondii-Derived Molecules: Possible Role of Carbohydrates.Front Immunol. 2021 Mar 10;11:612766. doi: 10.3389/fimmu.2020.612766. eCollection 2020. Front Immunol. 2021. PMID: 33776987 Free PMC article.
-
PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence.Virulence. 2022 Dec;13(1):1928-1942. doi: 10.1080/21505594.2022.2139474. Virulence. 2022. PMID: 36271710 Free PMC article.
-
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.EBioMedicine. 2018 May;31:66-78. doi: 10.1016/j.ebiom.2018.04.001. Epub 2018 Apr 5. EBioMedicine. 2018. PMID: 29678672 Free PMC article.
-
Hypoxia modeling techniques: A review.Heliyon. 2023 Feb;9(2):e13238. doi: 10.1016/j.heliyon.2023.e13238. Epub 2023 Jan 26. Heliyon. 2023. PMID: 36718422 Free PMC article. Review.
-
Oral tolerance as antigen-specific immunotherapy.Immunother Adv. 2021 Aug 25;1(1):ltab017. doi: 10.1093/immadv/ltab017. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919733 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous